UPC APP 25415/2025
EP4201327 Unitary patent · FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH
- Case details
- Status—ActionProcedural applicationCategoryConfidentiality (RoP 262A / 262.2)
- Parties
- Division
- Milan CD
- Judges
- —
- Technology
- InstrumentsMedical technology
- Language
- —
- First decided
- Jun 5, 2025
- EPO Opposition
- EOFlow Co., Ltd.Withdrawn2025-03-18
- KELLER SCHNEIDER PATENTANWALTS GMBHAdmissible2025-03-19
- Inspicos P/SWithdrawn2025-03-19
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Milan CD | Locked |
At the UPC: Insulet Corporation (25 cases)·EOFLOW Co., Ltd. (19 cases)
This dispute contains 18 other proceedings
UPC CFI 1230/2026·UPC CoA 34/2026·UPC CoA 930/2025·UPC CFI 1167/2025·UPC CFI 773/2025 and 13 more
3 other defendants litigating the same or a related patent
- 2025-06-05Application RoP262APublic
Summary: Milan Central Division confidentiality order (R. 262A RoP) in Insulet Corporation v. EOFLOW Co., Ltd. costs proceedings (EP 4 201 327). Insulet requested confidentiality for attorney fees and expenses in connection with its PI application. The court held that legal costs and attorney fees are not generally confidential, but may qualify for protection under R. 262A if they specifically reveal the company's financial capacity, commercial strategy, or the importance it attaches to the patent. The exhibits were partially classified as confidential on that basis.
Show the legal issues (3)
- Confidentiality of legal costs under R. 262A RoP
- Trade secrets in cost context (EU Directive 2016/943)
- Protection of financial capacity and commercial strategy information
- BF3761EC52C75F77DC9691DFC5DD5767_en.pdf2025-06-05EN